

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 7.14951724 |
| 2 | central nervous system myelination (GO:0022010) | 7.14951724 |
| 3 | fatty acid elongation (GO:0030497) | 4.88214641 |
| 4 | desmosome organization (GO:0002934) | 4.74810192 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.68522516 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 4.57087289 |
| 7 | negative regulation of cell killing (GO:0031342) | 4.55419799 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.55419799 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.52203495 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 4.52203495 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.52203495 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.52203495 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.52203495 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 4.52203495 |
| 15 | negative regulation of interleukin-12 production (GO:0032695) | 4.52018722 |
| 16 | response to peptidoglycan (GO:0032494) | 4.50591971 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.46295045 |
| 18 | creatine metabolic process (GO:0006600) | 4.28196080 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.13947710 |
| 20 | negative regulation of protein localization to cell surface (GO:2000009) | 4.05310067 |
| 21 | myelin maintenance (GO:0043217) | 4.03356370 |
| 22 | detection of other organism (GO:0098543) | 3.93372550 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.74983930 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.70988258 |
| 25 | detection of bacterium (GO:0016045) | 3.62952246 |
| 26 | cellular response to type I interferon (GO:0071357) | 3.54877690 |
| 27 | type I interferon signaling pathway (GO:0060337) | 3.54877690 |
| 28 | response to type I interferon (GO:0034340) | 3.54337328 |
| 29 | leukocyte aggregation (GO:0070486) | 3.53512044 |
| 30 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.50517853 |
| 31 | microglial cell activation (GO:0001774) | 3.46350824 |
| 32 | neutrophil activation (GO:0042119) | 3.46159141 |
| 33 | axon ensheathment (GO:0008366) | 3.44457391 |
| 34 | ensheathment of neurons (GO:0007272) | 3.44457391 |
| 35 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.43671284 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.43456720 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.43434311 |
| 38 | granulocyte activation (GO:0036230) | 3.42772506 |
| 39 | myelination (GO:0042552) | 3.36460060 |
| 40 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.33684829 |
| 41 | macrophage activation (GO:0042116) | 3.30744830 |
| 42 | immunoglobulin mediated immune response (GO:0016064) | 3.30197485 |
| 43 | myeloid cell activation involved in immune response (GO:0002275) | 3.28416156 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28003860 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.26696458 |
| 46 | amyloid precursor protein metabolic process (GO:0042982) | 3.26432345 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26049168 |
| 48 | negative regulation of T cell mediated immunity (GO:0002710) | 3.25328020 |
| 49 | germinal center formation (GO:0002467) | 3.23213842 |
| 50 | cellular extravasation (GO:0045123) | 3.22771999 |
| 51 | membrane tubulation (GO:0097320) | 3.21692913 |
| 52 | regulation of gamma-delta T cell activation (GO:0046643) | 3.21137684 |
| 53 | sarcomere organization (GO:0045214) | 3.20746893 |
| 54 | regulation of interferon-alpha production (GO:0032647) | 3.20517684 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19333667 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.16662030 |
| 57 | defense response to protozoan (GO:0042832) | 3.16105192 |
| 58 | protein localization to endosome (GO:0036010) | 3.15339629 |
| 59 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.11933269 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07743124 |
| 61 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.07493055 |
| 62 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.07383811 |
| 63 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.06941820 |
| 64 | detection of biotic stimulus (GO:0009595) | 3.06351583 |
| 65 | response to host immune response (GO:0052572) | 3.05014658 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05014658 |
| 67 | positive regulation of type 2 immune response (GO:0002830) | 3.04007666 |
| 68 | regulation of T cell tolerance induction (GO:0002664) | 3.03726349 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.02086716 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.01323822 |
| 71 | response to protozoan (GO:0001562) | 3.00012672 |
| 72 | neuron remodeling (GO:0016322) | 2.99868786 |
| 73 | regulation of mast cell activation (GO:0033003) | 2.99734312 |
| 74 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98580362 |
| 75 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.97433434 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.96541178 |
| 77 | positive regulation of interferon-alpha production (GO:0032727) | 2.94216703 |
| 78 | regulation of tolerance induction (GO:0002643) | 2.93764728 |
| 79 | sphingosine metabolic process (GO:0006670) | 2.91581976 |
| 80 | photoreceptor cell differentiation (GO:0046530) | 2.89969468 |
| 81 | eye photoreceptor cell differentiation (GO:0001754) | 2.89969468 |
| 82 | sphingoid metabolic process (GO:0046519) | 2.89123876 |
| 83 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.87591876 |
| 84 | positive regulation of mast cell degranulation (GO:0043306) | 2.87591876 |
| 85 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.87000045 |
| 86 | neutrophil mediated immunity (GO:0002446) | 2.86452511 |
| 87 | membrane raft organization (GO:0031579) | 2.85048379 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.84697264 |
| 89 | tolerance induction (GO:0002507) | 2.81289539 |
| 90 | negative regulation of interleukin-6 production (GO:0032715) | 2.78827445 |
| 91 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.78479974 |
| 92 | regulation of type 2 immune response (GO:0002828) | 2.77814650 |
| 93 | regulation of lipoprotein metabolic process (GO:0050746) | 2.77594188 |
| 94 | regulation of collateral sprouting (GO:0048670) | 2.77524322 |
| 95 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75775970 |
| 96 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73640351 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.73025649 |
| 98 | response to host (GO:0075136) | 2.73025649 |
| 99 | response to host defenses (GO:0052200) | 2.73025649 |
| 100 | establishment of mitochondrion localization (GO:0051654) | 2.72748418 |
| 101 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72563421 |
| 102 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.72187078 |
| 103 | leukocyte degranulation (GO:0043299) | 2.71802874 |
| 104 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.71733448 |
| 105 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.70825327 |
| 106 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.70401174 |
| 107 | myofibril assembly (GO:0030239) | 2.69671496 |
| 108 | regulation of actin filament-based movement (GO:1903115) | 2.69312057 |
| 109 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.67565577 |
| 110 | positive regulation of tolerance induction (GO:0002645) | 2.66878710 |
| 111 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66507548 |
| 112 | regulation of relaxation of muscle (GO:1901077) | 2.66402327 |
| 113 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.64645710 |
| 114 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.64341754 |
| 115 | regulation of antigen processing and presentation (GO:0002577) | 2.64036090 |
| 116 | regulation of interleukin-12 production (GO:0032655) | 2.61797801 |
| 117 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61774695 |
| 118 | interferon-gamma secretion (GO:0072643) | 2.60796291 |
| 119 | negative regulation of type 2 immune response (GO:0002829) | 2.60169722 |
| 120 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.59841233 |
| 121 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.59754594 |
| 122 | diol metabolic process (GO:0034311) | 2.59404890 |
| 123 | regulation of regulatory T cell differentiation (GO:0045589) | 2.59236103 |
| 124 | respiratory burst (GO:0045730) | 2.58285235 |
| 125 | cardiac myofibril assembly (GO:0055003) | 2.57737481 |
| 126 | positive regulation of interferon-beta production (GO:0032728) | 2.57463282 |
| 127 | regulation of leukocyte degranulation (GO:0043300) | 2.56615264 |
| 128 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.56309424 |
| 129 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.55840958 |
| 130 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.53907614 |
| 131 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.53573520 |
| 132 | response to methylmercury (GO:0051597) | 2.52523584 |
| 133 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.52361949 |
| 134 | response to interleukin-15 (GO:0070672) | 2.52135582 |
| 135 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.50072795 |
| 136 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.48249620 |
| 137 | extracellular matrix assembly (GO:0085029) | 2.47969828 |
| 138 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.47839114 |
| 139 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.46048282 |
| 140 | positive regulation of interleukin-17 production (GO:0032740) | 2.41312960 |
| 141 | potassium ion import (GO:0010107) | 2.41091952 |
| 142 | cellular response to interferon-alpha (GO:0035457) | 2.40775698 |
| 143 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.39421499 |
| 144 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.38676398 |
| 145 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.37305472 |
| 146 | hemidesmosome assembly (GO:0031581) | 2.33824667 |
| 147 | nerve growth factor signaling pathway (GO:0038180) | 2.33479874 |
| 148 | T-helper 1 type immune response (GO:0042088) | 2.32597836 |
| 149 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.32405369 |
| 150 | positive regulation of interleukin-4 production (GO:0032753) | 2.31665744 |
| 151 | positive regulation of actin filament depolymerization (GO:0030836) | 2.31384785 |
| 152 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.30245448 |
| 153 | magnesium ion transport (GO:0015693) | 2.27076159 |
| 154 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.26621904 |
| 155 | amyloid precursor protein catabolic process (GO:0042987) | 2.25698692 |
| 156 | regulation of interleukin-13 production (GO:0032656) | 2.25444158 |
| 157 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.25334291 |
| 158 | actin-myosin filament sliding (GO:0033275) | 2.25034462 |
| 159 | muscle filament sliding (GO:0030049) | 2.25034462 |
| 160 | keratinocyte proliferation (GO:0043616) | 2.24576621 |
| 161 | adhesion of symbiont to host cell (GO:0044650) | 2.23896596 |
| 162 | virion attachment to host cell (GO:0019062) | 2.23896596 |
| 163 | positive regulation of pseudopodium assembly (GO:0031274) | 2.23462119 |
| 164 | enteric nervous system development (GO:0048484) | 2.21678857 |
| 165 | tissue regeneration (GO:0042246) | 2.20054515 |
| 166 | negative regulation of chemokine production (GO:0032682) | 2.19677034 |
| 167 | atrioventricular valve morphogenesis (GO:0003181) | 2.19672169 |
| 168 | keratinization (GO:0031424) | 2.18827922 |
| 169 | oxygen transport (GO:0015671) | 2.18730067 |
| 170 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.18036566 |
| 171 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.16110702 |
| 172 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.14677383 |
| 173 | asymmetric protein localization (GO:0008105) | 2.11889121 |
| 174 | establishment of endothelial barrier (GO:0061028) | 2.11872606 |
| 175 | neutrophil activation involved in immune response (GO:0002283) | 2.10691690 |
| 176 | regulation of hypersensitivity (GO:0002883) | 2.10163026 |
| 177 | regulation of striated muscle contraction (GO:0006942) | 2.09997606 |
| 178 | regulation of pseudopodium assembly (GO:0031272) | 2.08696869 |
| 179 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.07505583 |
| 180 | plasma membrane repair (GO:0001778) | 2.05795470 |
| 181 | hypotonic response (GO:0006971) | 2.05613413 |
| 182 | axon development (GO:0061564) | 2.05252830 |
| 183 | regulation of water loss via skin (GO:0033561) | 2.04136707 |
| 184 | establishment of skin barrier (GO:0061436) | 2.03046174 |
| 185 | keratinocyte differentiation (GO:0030216) | 2.02874433 |
| 186 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.02640271 |
| 187 | regulation of natural killer cell differentiation (GO:0032823) | 2.02488732 |
| 188 | regulation of glomerular filtration (GO:0003093) | 2.00944652 |
| 189 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.00824351 |
| 190 | positive regulation of T cell cytokine production (GO:0002726) | 2.00523366 |
| 191 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 1.99519908 |
| 192 | mast cell activation (GO:0045576) | 1.99237640 |
| 193 | regulation of cardioblast differentiation (GO:0051890) | 1.97857279 |
| 194 | actin-mediated cell contraction (GO:0070252) | 1.97541081 |
| 195 | metanephric nephron epithelium development (GO:0072243) | 1.97340777 |
| 196 | endothelial cell development (GO:0001885) | 1.96782406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.94397955 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.38424583 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.02517450 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.39980921 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09430109 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.02891752 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02447255 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.96597453 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.92165030 |
| 10 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.85786479 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.84871718 |
| 12 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84846672 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81866605 |
| 14 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76157680 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.74307974 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70521535 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70374897 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.68379220 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66950169 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66487621 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64286580 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60730208 |
| 23 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59932107 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59260696 |
| 25 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.57126287 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.56278904 |
| 27 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53203389 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.52682114 |
| 29 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.48915302 |
| 30 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48874499 |
| 31 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.46895498 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46892160 |
| 33 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44285305 |
| 34 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41738759 |
| 35 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.40899831 |
| 36 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.40872491 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40425503 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37861962 |
| 39 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.37566446 |
| 40 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37284094 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.37223131 |
| 42 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.36890440 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.35780646 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.33885944 |
| 45 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.32129462 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30795463 |
| 47 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.29902955 |
| 48 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.29363213 |
| 49 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.29155561 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28456801 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.28232978 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.28232978 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27472514 |
| 54 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.27217667 |
| 55 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26672366 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.26370084 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25906625 |
| 58 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25257007 |
| 59 | * MYB_26560356_Chip-Seq_TH2_Human | 1.24993897 |
| 60 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24968394 |
| 61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23218070 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22845625 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22380799 |
| 64 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22271489 |
| 65 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22271489 |
| 66 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22223635 |
| 67 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.22108865 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21209656 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20652149 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18817089 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18731680 |
| 72 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18189513 |
| 73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17752078 |
| 74 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.17705833 |
| 75 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.15383710 |
| 76 | MAF_26560356_Chip-Seq_TH1_Human | 1.15150117 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14043804 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.13527166 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.13527166 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.13226516 |
| 81 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13108201 |
| 82 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11465602 |
| 83 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11251443 |
| 84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10681913 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10134991 |
| 86 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09449908 |
| 87 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09050645 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.08517455 |
| 89 | UTX_26944678_Chip-Seq_JUKART_Human | 1.07797242 |
| 90 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.07329284 |
| 91 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04938521 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03698594 |
| 93 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02644488 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02632146 |
| 95 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02188669 |
| 96 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.01214413 |
| 97 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01082697 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00870205 |
| 99 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.99470897 |
| 100 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98737318 |
| 101 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97768034 |
| 102 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97208931 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96717321 |
| 104 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.96262990 |
| 105 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95114768 |
| 106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94548473 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.94522645 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.94445942 |
| 109 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.93455461 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93412536 |
| 111 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93124348 |
| 112 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92228495 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 0.91775461 |
| 114 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91359852 |
| 115 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91056576 |
| 116 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90798260 |
| 117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90730482 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90319737 |
| 119 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89451279 |
| 120 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88922380 |
| 121 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.88671168 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88653012 |
| 123 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88647716 |
| 124 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88627462 |
| 125 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88127682 |
| 126 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.87413063 |
| 127 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86941220 |
| 128 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86357282 |
| 129 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84770560 |
| 130 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.84310189 |
| 131 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84111898 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.83975895 |
| 133 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83579177 |
| 134 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83403462 |
| 135 | MAF_26560356_Chip-Seq_TH2_Human | 0.83086274 |
| 136 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81496724 |
| 137 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81459214 |
| 138 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.81325461 |
| 139 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81106070 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80949508 |
| 141 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80331131 |
| 142 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.80203110 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79948898 |
| 144 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79610058 |
| 145 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79576262 |
| 146 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79552306 |
| 147 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79215503 |
| 148 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.78055578 |
| 149 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77933747 |
| 150 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.77925320 |
| 151 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77547179 |
| 152 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.77484356 |
| 153 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.77019211 |
| 154 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.76933670 |
| 155 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.76933670 |
| 156 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76930859 |
| 157 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76761166 |
| 158 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.76494154 |
| 159 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.76087025 |
| 160 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.75660374 |
| 161 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.75572832 |
| 162 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75076500 |
| 163 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74369697 |
| 164 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71272366 |
| 165 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.70363380 |
| 166 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.70029867 |
| 167 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.69519584 |
| 168 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69278268 |
| 169 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.68339293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.23178428 |
| 2 | MP0000920_abnormal_myelination | 3.22809845 |
| 3 | MP0002796_impaired_skin_barrier | 3.14788336 |
| 4 | MP0003646_muscle_fatigue | 3.12603306 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.03306122 |
| 6 | MP0005451_abnormal_body_composition | 2.69994371 |
| 7 | MP0001800_abnormal_humoral_immune | 2.43565215 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.41228903 |
| 9 | MP0004381_abnormal_hair_follicle | 2.34574094 |
| 10 | MP0010678_abnormal_skin_adnexa | 2.33547752 |
| 11 | MP0002723_abnormal_immune_serum | 2.30987836 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.30855518 |
| 13 | MP0000751_myopathy | 2.30667248 |
| 14 | MP0000383_abnormal_hair_follicle | 2.30239960 |
| 15 | MP0003724_increased_susceptibility_to | 2.26624848 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.23663564 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.22582950 |
| 18 | MP0004510_myositis | 2.22022456 |
| 19 | MP0009764_decreased_sensitivity_to | 2.16010558 |
| 20 | MP0003300_gastrointestinal_ulcer | 2.13138690 |
| 21 | MP0004043_abnormal_pH_regulation | 2.12769408 |
| 22 | MP0000749_muscle_degeneration | 2.06065665 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.05491989 |
| 24 | MP0001819_abnormal_immune_cell | 2.04316211 |
| 25 | MP0003329_amyloid_beta_deposits | 2.01726512 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.95876012 |
| 27 | MP0005275_abnormal_skin_tensile | 1.88989643 |
| 28 | MP0005330_cardiomyopathy | 1.85844482 |
| 29 | MP0005409_darkened_coat_color | 1.85172570 |
| 30 | MP0001851_eye_inflammation | 1.84155105 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.82230364 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.80576549 |
| 33 | MP0004215_abnormal_myocardial_fiber | 1.79522583 |
| 34 | MP0003453_abnormal_keratinocyte_physiol | 1.77926052 |
| 35 | MP0004484_altered_response_of | 1.73344473 |
| 36 | MP0002405_respiratory_system_inflammati | 1.70021414 |
| 37 | MP0005501_abnormal_skin_physiology | 1.66662609 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.66255371 |
| 39 | MP0009278_abnormal_bone_marrow | 1.65094101 |
| 40 | MP0000579_abnormal_nail_morphology | 1.64161093 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.58494305 |
| 42 | MP0002148_abnormal_hypersensitivity_rea | 1.57137323 |
| 43 | MP0001958_emphysema | 1.56244524 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.54758296 |
| 45 | MP0003828_pulmonary_edema | 1.47520016 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.44307945 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.43540342 |
| 48 | MP0002106_abnormal_muscle_physiology | 1.41894571 |
| 49 | MP0000716_abnormal_immune_system | 1.41716357 |
| 50 | MP0001216_abnormal_epidermal_layer | 1.41350863 |
| 51 | MP0005620_abnormal_muscle_contractility | 1.41310049 |
| 52 | MP0003137_abnormal_impulse_conducting | 1.40906122 |
| 53 | MP0009785_altered_susceptibility_to | 1.37856301 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.36108067 |
| 55 | MP0005165_increased_susceptibility_to | 1.35462764 |
| 56 | MP0008469_abnormal_protein_level | 1.33281521 |
| 57 | MP0004858_abnormal_nervous_system | 1.32905151 |
| 58 | MP0004947_skin_inflammation | 1.32281607 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.31944534 |
| 60 | MP0003763_abnormal_thymus_physiology | 1.31611163 |
| 61 | MP0003303_peritoneal_inflammation | 1.31529617 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.30033303 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.28008409 |
| 64 | MP0000343_altered_response_to | 1.27245385 |
| 65 | MP0005310_abnormal_salivary_gland | 1.26899038 |
| 66 | MP0010771_integument_phenotype | 1.26389240 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 1.25440015 |
| 68 | MP0008260_abnormal_autophagy | 1.25303254 |
| 69 | MP0005166_decreased_susceptibility_to | 1.23480267 |
| 70 | MP0003880_abnormal_central_pattern | 1.21273615 |
| 71 | MP0006082_CNS_inflammation | 1.20988594 |
| 72 | MP0002398_abnormal_bone_marrow | 1.20659086 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 1.20104413 |
| 74 | MP0006138_congestive_heart_failure | 1.19899051 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.18992053 |
| 76 | MP0001765_abnormal_ion_homeostasis | 1.18668455 |
| 77 | MP0005385_cardiovascular_system_phenoty | 1.18068155 |
| 78 | MP0001544_abnormal_cardiovascular_syste | 1.18068155 |
| 79 | MP0003690_abnormal_glial_cell | 1.16331008 |
| 80 | MP0005369_muscle_phenotype | 1.16243179 |
| 81 | MP0005387_immune_system_phenotype | 1.16152803 |
| 82 | MP0001790_abnormal_immune_system | 1.16152803 |
| 83 | MP0005397_hematopoietic_system_phenotyp | 1.14952040 |
| 84 | MP0001545_abnormal_hematopoietic_system | 1.14952040 |
| 85 | MP0005164_abnormal_response_to | 1.14303243 |
| 86 | MP0005000_abnormal_immune_tolerance | 1.13257645 |
| 87 | MP0004883_abnormal_blood_vessel | 1.12650837 |
| 88 | MP0000747_muscle_weakness | 1.12225744 |
| 89 | MP0004130_abnormal_muscle_cell | 1.10666226 |
| 90 | MP0010630_abnormal_cardiac_muscle | 1.10210026 |
| 91 | MP0000647_abnormal_sebaceous_gland | 1.09788558 |
| 92 | MP0002060_abnormal_skin_morphology | 1.08691229 |
| 93 | MP0003183_abnormal_peptide_metabolism | 1.07983084 |
| 94 | MP0004742_abnormal_vestibular_system | 1.07385168 |
| 95 | MP0000604_amyloidosis | 1.06874762 |
| 96 | MP0003941_abnormal_skin_development | 1.05488935 |
| 97 | MP0003045_fibrosis | 1.03164147 |
| 98 | MP0005390_skeleton_phenotype | 1.02835300 |
| 99 | MP0001853_heart_inflammation | 1.02499818 |
| 100 | MP0002332_abnormal_exercise_endurance | 1.02165412 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02107814 |
| 102 | MP0000858_altered_metastatic_potential | 1.02075584 |
| 103 | MP0000762_abnormal_tongue_morphology | 1.01849017 |
| 104 | MP0008004_abnormal_stomach_pH | 1.00790256 |
| 105 | MP0003566_abnormal_cell_adhesion | 1.00589054 |
| 106 | MP0005025_abnormal_response_to | 0.99547413 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.99280738 |
| 108 | MP0002429_abnormal_blood_cell | 0.97761040 |
| 109 | MP0003634_abnormal_glial_cell | 0.96065307 |
| 110 | MP0003866_abnormal_defecation | 0.95458072 |
| 111 | MP0003075_altered_response_to | 0.94664799 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.93635968 |
| 113 | MP0001663_abnormal_digestive_system | 0.91090879 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.90997681 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.90555521 |
| 116 | MP0008874_decreased_physiological_sensi | 0.89734673 |
| 117 | MP0004085_abnormal_heartbeat | 0.89458986 |
| 118 | MP0002722_abnormal_immune_system | 0.88844212 |
| 119 | MP0005171_absent_coat_pigmentation | 0.88625989 |
| 120 | MP0008569_lethality_at_weaning | 0.88447804 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.88437317 |
| 122 | MP0000759_abnormal_skeletal_muscle | 0.88397577 |
| 123 | MP0000685_abnormal_immune_system | 0.88084432 |
| 124 | MP0003633_abnormal_nervous_system | 0.86660451 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.86488355 |
| 126 | MP0004782_abnormal_surfactant_physiolog | 0.85090877 |
| 127 | MP0004142_abnormal_muscle_tone | 0.84686636 |
| 128 | MP0009333_abnormal_splenocyte_physiolog | 0.84677193 |
| 129 | MP0003879_abnormal_hair_cell | 0.84637070 |
| 130 | MP0009840_abnormal_foam_cell | 0.84142230 |
| 131 | MP0005388_respiratory_system_phenotype | 0.84035598 |
| 132 | MP0002133_abnormal_respiratory_system | 0.84035598 |
| 133 | MP0000377_abnormal_hair_follicle | 0.84006115 |
| 134 | MP0003436_decreased_susceptibility_to | 0.82247125 |
| 135 | MP0003136_yellow_coat_color | 0.82239613 |
| 136 | MP0002006_tumorigenesis | 0.81706062 |
| 137 | MP0000750_abnormal_muscle_regeneration | 0.81435471 |
| 138 | MP0003631_nervous_system_phenotype | 0.80952978 |
| 139 | MP0001905_abnormal_dopamine_level | 0.80692361 |
| 140 | MP0005671_abnormal_response_to | 0.80648941 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.80511640 |
| 142 | MP0003195_calcinosis | 0.79806654 |
| 143 | MP0001346_abnormal_lacrimal_gland | 0.78296125 |
| 144 | MP0002138_abnormal_hepatobiliary_system | 0.77651566 |
| 145 | MP0002933_joint_inflammation | 0.77557609 |
| 146 | MP0002419_abnormal_innate_immunity | 0.77285804 |
| 147 | MP0010234_abnormal_vibrissa_follicle | 0.75894037 |
| 148 | MP0009763_increased_sensitivity_to | 0.75542105 |
| 149 | MP0003448_altered_tumor_morphology | 0.74712242 |
| 150 | MP0000569_abnormal_digit_pigmentation | 0.73171831 |
| 151 | MP0002132_abnormal_respiratory_system | 0.71698447 |
| 152 | MP0002064_seizures | 0.67787558 |
| 153 | MP0005535_abnormal_body_temperature | 0.65645273 |
| 154 | MP0001542_abnormal_bone_strength | 0.65488217 |
| 155 | MP0006054_spinal_hemorrhage | 0.64475517 |
| 156 | MP0003656_abnormal_erythrocyte_physiolo | 0.63874657 |
| 157 | MP0002653_abnormal_ependyma_morphology | 0.61823606 |
| 158 | MP0000703_abnormal_thymus_morphology | 0.61382524 |
| 159 | MP0009745_abnormal_behavioral_response | 0.59679277 |
| 160 | MP0000249_abnormal_blood_vessel | 0.58799211 |
| 161 | MP0002254_reproductive_system_inflammat | 0.56779905 |
| 162 | MP0001970_abnormal_pain_threshold | 0.54963793 |
| 163 | MP0005381_digestive/alimentary_phenotyp | 0.54318057 |
| 164 | MP0001986_abnormal_taste_sensitivity | 0.54132348 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Orchitis (HP:0100796) | 5.89629802 |
| 2 | Optic neuritis (HP:0100653) | 5.86049634 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 5.86049634 |
| 4 | Myositis (HP:0100614) | 5.80876015 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.26627095 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.99959531 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.78554614 |
| 8 | Parakeratosis (HP:0001036) | 4.65731474 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 4.57892452 |
| 10 | Neurofibrillary tangles (HP:0002185) | 4.27955162 |
| 11 | Keratoconjunctivitis sicca (HP:0001097) | 4.22816267 |
| 12 | Ventricular tachycardia (HP:0004756) | 4.22244317 |
| 13 | Sudden death (HP:0001699) | 4.20573011 |
| 14 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.99274372 |
| 15 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.99274372 |
| 16 | Keratoconjunctivitis (HP:0001096) | 3.96927201 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.95990555 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.95990555 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.95990555 |
| 20 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.94950327 |
| 21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.85883529 |
| 22 | Calf muscle hypertrophy (HP:0008981) | 3.67575383 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.60274175 |
| 24 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.60246155 |
| 25 | Hypokalemic alkalosis (HP:0001949) | 3.45742799 |
| 26 | Increased circulating renin level (HP:0000848) | 3.36231613 |
| 27 | Recurrent fungal infections (HP:0002841) | 3.32555005 |
| 28 | Metabolic alkalosis (HP:0200114) | 3.29535286 |
| 29 | Difficulty running (HP:0009046) | 3.26494922 |
| 30 | Autoimmune thrombocytopenia (HP:0001973) | 3.26320704 |
| 31 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.25466451 |
| 32 | Pulmonary infiltrates (HP:0002113) | 3.22567122 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 3.21229799 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 3.19602686 |
| 35 | Recurrent skin infections (HP:0001581) | 3.18227807 |
| 36 | Axonal loss (HP:0003447) | 3.17552763 |
| 37 | Hemoptysis (HP:0002105) | 3.13284269 |
| 38 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.12455355 |
| 39 | Onion bulb formation (HP:0003383) | 3.11272236 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.10182550 |
| 41 | Exercise-induced myalgia (HP:0003738) | 3.10162221 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.09798935 |
| 43 | Abnormality of the calf musculature (HP:0001430) | 3.08423667 |
| 44 | Vasculitis (HP:0002633) | 3.06920194 |
| 45 | Atrial fibrillation (HP:0005110) | 3.05990817 |
| 46 | Encephalitis (HP:0002383) | 3.04656779 |
| 47 | Peripheral hypomyelination (HP:0007182) | 2.99537436 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.99097836 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 2.96050365 |
| 50 | Episodic fever (HP:0001954) | 2.95293868 |
| 51 | Gingivitis (HP:0000230) | 2.93123914 |
| 52 | Hypomagnesemia (HP:0002917) | 2.91404484 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.91167730 |
| 54 | Obstructive lung disease (HP:0006536) | 2.87477434 |
| 55 | Chronic obstructive pulmonary disease (HP:0006510) | 2.87477434 |
| 56 | Meningitis (HP:0001287) | 2.87145118 |
| 57 | Primary atrial arrhythmia (HP:0001692) | 2.85061996 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.85027494 |
| 59 | Amyloidosis (HP:0011034) | 2.78816295 |
| 60 | Loss of speech (HP:0002371) | 2.76353476 |
| 61 | Termporal pattern (HP:0011008) | 2.74182852 |
| 62 | Insidious onset (HP:0003587) | 2.74182852 |
| 63 | Hypotrichosis (HP:0001006) | 2.70264634 |
| 64 | Supraventricular tachycardia (HP:0004755) | 2.69084840 |
| 65 | Stomatitis (HP:0010280) | 2.66253691 |
| 66 | Supraventricular arrhythmia (HP:0005115) | 2.66232255 |
| 67 | Increased IgM level (HP:0003496) | 2.65349687 |
| 68 | Urticaria (HP:0001025) | 2.64239880 |
| 69 | Cerebral hemorrhage (HP:0001342) | 2.63760675 |
| 70 | Arterial thrombosis (HP:0004420) | 2.61859948 |
| 71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.60925923 |
| 72 | Disinhibition (HP:0000734) | 2.60538950 |
| 73 | Syncope (HP:0001279) | 2.60101931 |
| 74 | Vertigo (HP:0002321) | 2.59795694 |
| 75 | EMG: myopathic abnormalities (HP:0003458) | 2.59330542 |
| 76 | Foot dorsiflexor weakness (HP:0009027) | 2.59005193 |
| 77 | Leukocytosis (HP:0001974) | 2.56672395 |
| 78 | Gangrene (HP:0100758) | 2.56525657 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.54657544 |
| 80 | Spontaneous hematomas (HP:0007420) | 2.54125538 |
| 81 | Hypoplasia of the iris (HP:0007676) | 2.49309229 |
| 82 | Ankle clonus (HP:0011448) | 2.47622928 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.46525527 |
| 84 | Recurrent cutaneous fungal infections (HP:0011370) | 2.46525527 |
| 85 | Lipoatrophy (HP:0100578) | 2.42970529 |
| 86 | Exercise-induced muscle cramps (HP:0003710) | 2.42385822 |
| 87 | Anorexia (HP:0002039) | 2.40861224 |
| 88 | Abnormality of the foot musculature (HP:0001436) | 2.40682703 |
| 89 | Chest pain (HP:0100749) | 2.39319120 |
| 90 | Abnormality of T cell number (HP:0011839) | 2.39030058 |
| 91 | Supranuclear gaze palsy (HP:0000605) | 2.38674042 |
| 92 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38156691 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38156691 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38156691 |
| 95 | Mutism (HP:0002300) | 2.36317545 |
| 96 | Pulmonary embolism (HP:0002204) | 2.34087841 |
| 97 | Peritonitis (HP:0002586) | 2.33951695 |
| 98 | T lymphocytopenia (HP:0005403) | 2.33707396 |
| 99 | Alveolar cell carcinoma (HP:0006519) | 2.32145071 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 2.26331769 |
| 101 | Gowers sign (HP:0003391) | 2.24549340 |
| 102 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.23713979 |
| 103 | Diplopia (HP:0000651) | 2.23500711 |
| 104 | Abnormality of binocular vision (HP:0011514) | 2.23500711 |
| 105 | Hyperaldosteronism (HP:0000859) | 2.22811091 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.22809714 |
| 107 | Abnormality of the pleura (HP:0002103) | 2.21548806 |
| 108 | Abnormality of the endocardium (HP:0004306) | 2.21333815 |
| 109 | Neck muscle weakness (HP:0000467) | 2.21300809 |
| 110 | Abnormality of chloride homeostasis (HP:0011422) | 2.20555808 |
| 111 | Abnormal auditory evoked potentials (HP:0006958) | 2.20369372 |
| 112 | Vacuolated lymphocytes (HP:0001922) | 2.19875792 |
| 113 | Pustule (HP:0200039) | 2.19365922 |
| 114 | Diaphragmatic weakness (HP:0009113) | 2.18547323 |
| 115 | Keratitis (HP:0000491) | 2.16640626 |
| 116 | Stridor (HP:0010307) | 2.16144526 |
| 117 | Abnormality of the salivary glands (HP:0010286) | 2.16101349 |
| 118 | Erythroderma (HP:0001019) | 2.15831349 |
| 119 | Mucopolysacchariduria (HP:0008155) | 2.15244324 |
| 120 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.15244324 |
| 121 | Abnormality of magnesium homeostasis (HP:0004921) | 2.14698821 |
| 122 | Ventricular fibrillation (HP:0001663) | 2.14295388 |
| 123 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.13173679 |
| 124 | Prolonged QT interval (HP:0001657) | 2.12908103 |
| 125 | Palmoplantar keratoderma (HP:0000982) | 2.12736279 |
| 126 | Hypochromic microcytic anemia (HP:0004840) | 2.12125400 |
| 127 | Increased IgE level (HP:0003212) | 2.11165166 |
| 128 | Increased serum ferritin (HP:0003281) | 2.10611660 |
| 129 | Abnormality of the pericardium (HP:0001697) | 2.10459665 |
| 130 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.09910228 |
| 131 | Subaortic stenosis (HP:0001682) | 2.09910228 |
| 132 | Agitation (HP:0000713) | 2.09827776 |
| 133 | Abnormality of renin-angiotensin system (HP:0000847) | 2.09603016 |
| 134 | Hematochezia (HP:0002573) | 2.09010080 |
| 135 | Hypochromic anemia (HP:0001931) | 2.07536376 |
| 136 | Abnormal drinking behavior (HP:0030082) | 2.05692613 |
| 137 | Polydipsia (HP:0001959) | 2.05692613 |
| 138 | Hemiplegia (HP:0002301) | 2.04261923 |
| 139 | Renal salt wasting (HP:0000127) | 2.03091391 |
| 140 | Purpura (HP:0000979) | 2.02337180 |
| 141 | Hyperactive renin-angiotensin system (HP:0000841) | 2.01973962 |
| 142 | Acne (HP:0001061) | 2.01796502 |
| 143 | Polyneuropathy (HP:0001271) | 2.00180538 |
| 144 | Memory impairment (HP:0002354) | 1.99111985 |
| 145 | Dilated cardiomyopathy (HP:0001644) | 1.97763286 |
| 146 | Gingival bleeding (HP:0000225) | 1.97573968 |
| 147 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.96708569 |
| 148 | Inappropriate behavior (HP:0000719) | 1.96074477 |
| 149 | Plantar hyperkeratosis (HP:0007556) | 1.95787996 |
| 150 | Slow saccadic eye movements (HP:0000514) | 1.95688115 |
| 151 | Polyuria (HP:0000103) | 1.94093886 |
| 152 | Thick nail (HP:0001805) | 1.93111143 |
| 153 | Conical tooth (HP:0000698) | 1.91443117 |
| 154 | Petechiae (HP:0000967) | 1.91271761 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.90918202 |
| 156 | Fragile nails (HP:0001808) | 1.90861729 |
| 157 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.90746427 |
| 158 | Aplasia of the phalanges of the hand (HP:0009802) | 1.90746427 |
| 159 | Aplasia involving bones of the extremities (HP:0009825) | 1.90746427 |
| 160 | Rapidly progressive (HP:0003678) | 1.88290622 |
| 161 | Steppage gait (HP:0003376) | 1.88082813 |
| 162 | Epistaxis (HP:0000421) | 1.87771485 |
| 163 | Obstructive sleep apnea (HP:0002870) | 1.87236432 |
| 164 | Interstitial pulmonary disease (HP:0006530) | 1.86052461 |
| 165 | Eosinophilia (HP:0001880) | 1.85574150 |
| 166 | Distal lower limb muscle weakness (HP:0009053) | 1.85372023 |
| 167 | Recurrent viral infections (HP:0004429) | 1.83433833 |
| 168 | Abnormality of iron homeostasis (HP:0011031) | 1.81751619 |
| 169 | Autoimmune hemolytic anemia (HP:0001890) | 1.80928778 |
| 170 | Stomach cancer (HP:0012126) | 1.80824996 |
| 171 | Erythema (HP:0010783) | 1.79381284 |
| 172 | Dysmetria (HP:0001310) | 1.78796549 |
| 173 | Ulnar claw (HP:0001178) | 1.78495083 |
| 174 | Chronic otitis media (HP:0000389) | 1.78218451 |
| 175 | Increased serum pyruvate (HP:0003542) | 1.78171371 |
| 176 | Abnormality of glycolysis (HP:0004366) | 1.78171371 |
| 177 | Abnormality of renal excretion (HP:0011036) | 1.77464655 |
| 178 | Difficulty walking (HP:0002355) | 1.77367686 |
| 179 | Anhidrosis (HP:0000970) | 1.77329026 |
| 180 | Intention tremor (HP:0002080) | 1.73319993 |
| 181 | Spastic tetraparesis (HP:0001285) | 1.73130039 |
| 182 | Abnormal urine output (HP:0012590) | 1.72736374 |
| 183 | Recurrent bacterial skin infections (HP:0005406) | 1.71446024 |
| 184 | Recurrent abscess formation (HP:0002722) | 1.70851539 |
| 185 | Milia (HP:0001056) | 1.69818181 |
| 186 | Premature skin wrinkling (HP:0100678) | 1.69460747 |
| 187 | Lip pit (HP:0100267) | 1.67823455 |
| 188 | Pterygium (HP:0001059) | 1.66402125 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.94353654 |
| 2 | EPHB1 | 4.03898402 |
| 3 | MAPKAPK5 | 3.41678275 |
| 4 | WNK4 | 3.41480960 |
| 5 | OXSR1 | 3.21527852 |
| 6 | MAP4K1 | 2.60767441 |
| 7 | IRAK4 | 2.53498727 |
| 8 | PKN1 | 2.38556247 |
| 9 | PBK | 2.29661665 |
| 10 | DMPK | 1.99942369 |
| 11 | FES | 1.98713769 |
| 12 | MST4 | 1.96944202 |
| 13 | TTN | 1.94254571 |
| 14 | MAP2K3 | 1.85597443 |
| 15 | PHKG2 | 1.83308604 |
| 16 | PHKG1 | 1.83308604 |
| 17 | MUSK | 1.78077896 |
| 18 | MAP3K11 | 1.72792251 |
| 19 | ZAP70 | 1.72452512 |
| 20 | PRPF4B | 1.71605839 |
| 21 | WNK1 | 1.68261757 |
| 22 | TNK2 | 1.67609480 |
| 23 | IRAK3 | 1.66298406 |
| 24 | ERN1 | 1.56854650 |
| 25 | RIPK1 | 1.48469931 |
| 26 | OBSCN | 1.44413659 |
| 27 | DAPK2 | 1.44393436 |
| 28 | MATK | 1.43423929 |
| 29 | SYK | 1.42546849 |
| 30 | TRPM7 | 1.40860893 |
| 31 | IRAK1 | 1.40020012 |
| 32 | GRK6 | 1.39548937 |
| 33 | GRK7 | 1.35536208 |
| 34 | TIE1 | 1.32626377 |
| 35 | MAP3K6 | 1.31078027 |
| 36 | PRKD1 | 1.25778337 |
| 37 | LIMK1 | 1.22999065 |
| 38 | BTK | 1.20082162 |
| 39 | LYN | 1.19983861 |
| 40 | MARK2 | 1.19543545 |
| 41 | TAOK2 | 1.18678505 |
| 42 | ROCK2 | 1.18001553 |
| 43 | MARK3 | 1.16822729 |
| 44 | ADRBK2 | 1.15287686 |
| 45 | EPHA3 | 1.14106278 |
| 46 | FGFR2 | 1.13833445 |
| 47 | MOS | 1.11762760 |
| 48 | JAK2 | 1.09855134 |
| 49 | IRAK2 | 1.08779932 |
| 50 | NTRK1 | 1.08738043 |
| 51 | MAP3K14 | 1.08676894 |
| 52 | KIT | 1.05494912 |
| 53 | FRK | 1.01860674 |
| 54 | MET | 1.01493936 |
| 55 | PIM2 | 1.01260747 |
| 56 | CSF1R | 1.00701068 |
| 57 | JAK3 | 1.00223981 |
| 58 | DYRK2 | 0.99239426 |
| 59 | FGR | 0.98998651 |
| 60 | TYK2 | 0.98763230 |
| 61 | SIK2 | 0.98751895 |
| 62 | CLK1 | 0.97628391 |
| 63 | BMPR2 | 0.97521021 |
| 64 | TYRO3 | 0.93736395 |
| 65 | CAMK2D | 0.91935264 |
| 66 | CDC42BPA | 0.91446624 |
| 67 | MST1R | 0.91103299 |
| 68 | PAK3 | 0.87445205 |
| 69 | SGK223 | 0.84521743 |
| 70 | SGK494 | 0.84521743 |
| 71 | MYLK | 0.83357625 |
| 72 | IKBKE | 0.82685572 |
| 73 | TBK1 | 0.81863762 |
| 74 | CAMK2A | 0.80970808 |
| 75 | CSNK1G3 | 0.79081705 |
| 76 | SIK3 | 0.78386986 |
| 77 | FER | 0.77748956 |
| 78 | UHMK1 | 0.77215597 |
| 79 | PDK1 | 0.76781592 |
| 80 | WNK3 | 0.76757629 |
| 81 | BLK | 0.76616524 |
| 82 | STK24 | 0.76550698 |
| 83 | BCR | 0.76393908 |
| 84 | PRKD2 | 0.76175639 |
| 85 | CSNK1A1L | 0.76073254 |
| 86 | MAP3K1 | 0.74232572 |
| 87 | CAMKK2 | 0.73990205 |
| 88 | RIPK4 | 0.73727424 |
| 89 | CAMK2B | 0.73062447 |
| 90 | PRKCQ | 0.72876497 |
| 91 | PRKCE | 0.70825606 |
| 92 | ILK | 0.70720637 |
| 93 | LRRK2 | 0.69477096 |
| 94 | STK10 | 0.69250357 |
| 95 | KSR2 | 0.68966980 |
| 96 | MAP3K2 | 0.68363017 |
| 97 | CAMKK1 | 0.68287436 |
| 98 | PTK2B | 0.68256499 |
| 99 | MAP3K12 | 0.67802442 |
| 100 | CHUK | 0.67564020 |
| 101 | MAP2K6 | 0.66978612 |
| 102 | CSNK1G2 | 0.66970719 |
| 103 | TXK | 0.66793683 |
| 104 | ITK | 0.66699891 |
| 105 | PRKD3 | 0.66377326 |
| 106 | CSNK1G1 | 0.65457263 |
| 107 | CSK | 0.64671734 |
| 108 | PAK6 | 0.63588607 |
| 109 | SGK3 | 0.63385321 |
| 110 | GSK3A | 0.63109467 |
| 111 | MAPK7 | 0.63010990 |
| 112 | BMPR1B | 0.62793370 |
| 113 | ABL2 | 0.61230136 |
| 114 | SGK2 | 0.60907892 |
| 115 | JAK1 | 0.60700587 |
| 116 | TEC | 0.60588885 |
| 117 | MAP3K13 | 0.60088089 |
| 118 | CAMK1 | 0.59516579 |
| 119 | RPS6KA6 | 0.58077110 |
| 120 | LMTK2 | 0.57830226 |
| 121 | YES1 | 0.57355246 |
| 122 | NTRK2 | 0.56366149 |
| 123 | HIPK2 | 0.56363354 |
| 124 | PINK1 | 0.56244022 |
| 125 | STK38 | 0.56091994 |
| 126 | PIK3CA | 0.55325615 |
| 127 | ACVR1B | 0.55272016 |
| 128 | RPS6KC1 | 0.53237097 |
| 129 | RPS6KL1 | 0.53237097 |
| 130 | MAP3K5 | 0.53088987 |
| 131 | PDPK1 | 0.52452876 |
| 132 | HCK | 0.52347846 |
| 133 | LCK | 0.50959735 |
| 134 | DDR2 | 0.49508539 |
| 135 | MAPKAPK2 | 0.48480185 |
| 136 | RPS6KA2 | 0.48108454 |
| 137 | CAMK4 | 0.46889078 |
| 138 | CAMK2G | 0.46756634 |
| 139 | MAP3K9 | 0.46375696 |
| 140 | TAOK3 | 0.46324633 |
| 141 | TAOK1 | 0.45266714 |
| 142 | ABL1 | 0.44912574 |
| 143 | MAPK12 | 0.44387782 |
| 144 | PIM1 | 0.44361280 |
| 145 | MAP3K3 | 0.44177981 |
| 146 | PDGFRB | 0.43920085 |
| 147 | STK11 | 0.43678648 |
| 148 | FYN | 0.43532131 |
| 149 | PRKCZ | 0.43255965 |
| 150 | IKBKB | 0.42669472 |
| 151 | ADRBK1 | 0.41519743 |
| 152 | TGFBR2 | 0.41513482 |
| 153 | NTRK3 | 0.41376845 |
| 154 | MAPK4 | 0.38401615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.97481522 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.71568617 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.38395449 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.35749523 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.09595691 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.79216582 |
| 7 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.73007099 |
| 8 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.66532697 |
| 9 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.64981428 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55193510 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.52610953 |
| 12 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51306038 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50990910 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.50919206 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.50498147 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.49545450 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49540270 |
| 18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.49448756 |
| 19 | Allograft rejection_Homo sapiens_hsa05330 | 1.46788750 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.45767120 |
| 21 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.42200078 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.41786377 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35493284 |
| 24 | Lysosome_Homo sapiens_hsa04142 | 1.34528559 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.29895747 |
| 26 | Influenza A_Homo sapiens_hsa05164 | 1.29702609 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.22888551 |
| 28 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.22193439 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17328541 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17095144 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.16977765 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.15646122 |
| 33 | Parkinsons disease_Homo sapiens_hsa05012 | 1.14645385 |
| 34 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13348255 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.10956623 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.10503168 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.09562800 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.09241075 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07981945 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07947059 |
| 41 | Axon guidance_Homo sapiens_hsa04360 | 1.07188205 |
| 42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07103308 |
| 43 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05863070 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.03683473 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.02084986 |
| 46 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01331456 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00203834 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00164996 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.97977916 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.95824138 |
| 51 | Long-term depression_Homo sapiens_hsa04730 | 0.95699885 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.95057548 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94529074 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.94184044 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93740294 |
| 56 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93373221 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 0.93017312 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92401996 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92098673 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89189518 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88465373 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.88064585 |
| 63 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87640309 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.85795688 |
| 65 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.85762904 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85230400 |
| 67 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83596286 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.83253596 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.82949882 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82555405 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82102452 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.81784825 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80785804 |
| 74 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.80019403 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.79239207 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78199836 |
| 77 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77859591 |
| 78 | Morphine addiction_Homo sapiens_hsa05032 | 0.77628495 |
| 79 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76595528 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75618760 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.75100433 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74710377 |
| 83 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74453164 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74009328 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.71301106 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70826131 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.69773369 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69094767 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.68207463 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67802429 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67674565 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.67004265 |
| 93 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66787120 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65836486 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65309907 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65297914 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63685858 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63670242 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62775775 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.62686727 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.62385691 |
| 102 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62164814 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62161950 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.61380743 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60921073 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.60763665 |
| 107 | Tuberculosis_Homo sapiens_hsa05152 | 0.59681490 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59564478 |
| 109 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58733265 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58094843 |
| 111 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57628713 |
| 112 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57542141 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57252200 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57173173 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.56981211 |
| 116 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56121463 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55610298 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55451501 |
| 119 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55279400 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55244878 |
| 121 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54830068 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54157568 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53702364 |
| 124 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52959072 |
| 125 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52748280 |
| 126 | Circadian entrainment_Homo sapiens_hsa04713 | 0.52501872 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52251295 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.51490823 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50751711 |
| 130 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49558829 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48984929 |
| 132 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.47177252 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41052255 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41021665 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39481458 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.38658343 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38462374 |
| 138 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37907277 |

